Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Thanks to both BaNosser and Wolf,

I think that it was TPL who requested more time b/c Barco would not come forth with the materials TPL needed to do the work required. The SM said that Barco was required to present the materials and gave a deadline for the amendments---which would have been the 26th. It looks to me like Barco is throwing stuff at the wall now--WHEREAS, claims 7, 10, 14, and 16 of the ‘336 patent were inadvertently omitted from Barco’s Proposed Order (Dkt. 238-5) and Reply Brief (Dkt. 266);------again, they are omitting information that should have been included a long time ago. IMHO, TPL is standing tall in this matter by agreeing to amend the additional claims. They have 4 more days in which to get the job done, but I would wager that they are either well on their way to having it done or have it done already! Corrections are welcomed. GL, ads

ps BaNosser, Thank you for watching for the Markman rulings--I feel that we may get them at anytime now. :)

Share
New Message
Please login to post a reply